Hospinova Distribuidora de Produtos Hospitalares

What Hospinova Distribuidora de Produtos Hospitalares does

Hospinova is a Brazilian pharmaceutical and hospital-product distributor founded in 2014 and operating under Grupo Venancio. The company distributes 5,000+ medication SKUs sourced from 70+ laboratory partners to more than 1,400 healthcare institutions across all 26 Brazilian states and the Federal District. Operations are anchored by three owned distribution centers totaling 23,300 m² in Rio de Janeiro (12,000 m²), Espírito Santo (6,500 m²), and Minas Gerais (4,800 m²), with corporate headquarters in Rio de Janeiro.

The business model is B2B institutional distribution with two parallel commercial channels: direct sales to hospitals, clinics, and health-plan operators, and participation in public-sector tenders (licitações). Regulatory compliance is a core operating requirement, with active maintenance of ANVIA authorization, ISO 9001:2015 quality management certification, RDC 430/2020 adherence, and SNGPC integration for controlled-substance tracking. A consumer-facing sub-brand, VNova Delivery, extends the model into direct-to-patient medication delivery, indicating a deliberate channel-extension strategy beyond pure institutional sales. Pharmaceutical benefit management services for health-plan operators represent an additional service layer aimed at deepening wallet share within existing accounts.

Name

Hospinova Distribuidora de Produtos Hospitalares

Legal name

Hospinova Distribuidora de Produtos Hospitalares

Website

https://hospinova.com.br

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Brazilian pharmaceutical distributor under Grupo Venancio serving 1,400+ healthcare institutions across 26 states via three distribution centers with 5,000+ medication SKUs, operating B2B institutional sales and the VNova Delivery B2C channel.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)

Keywords

• Pharmaceutical distribution
• Hospital supply logistics
• Cold chain logistics
• Healthcare procurement
• Medication traceability

Headquarters

HQ city

Rio de Janeiro

HQ country

Brazil

HQ region

Latin America

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales, Others

Revenue model

1. Pharmaceutical Product Distribution: Distribution of high-cost medications including ethical, generic, similar, biological, and imported drugs to healthcare institutions. Revenue generated through direct product sales, public tender contracts (licitações), and registration of prices (SRP) agreements. Handles over 5,000 pharmaceutical product items from 70+ partner laboratories.
2. Pharmaceutical Services: Additional services including traceability and monitoring, intelligent storage, pharmaceutical support, operational management, and technology solutions. Revenue from service contracts bundled with product distribution.
3. VNova Delivery (Patient Direct): Direct-to-patient delivery service through VNova Delivery brand, providing medications to individual patients (pessoa física) via WhatsApp ordering.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Hospinova Distribuidora de Produtos Hospitalares is a specialized national pharmaceutical distributor that sells high-cost medications (ethical, generic, similar, biological, and imported) to hospitals, clinics, health insurance operators, and Brazilian public health agencies. It distributes more than 5,000 SKUs from 70+ laboratory partners across 26 states and the Federal District, with temperature-controlled cold chain logistics, GPS-monitored deliveries, and SNGPC-integrated traceability. Through its VNova Delivery sub-brand, it also delivers medications directly to individual patients via WhatsApp ordering.

Product overview

Hospinova Distribuidora Farmacêutica operates as a national pharmaceutical distribution platform built around a core B2B distribution service supplemented by technology-enabled service modules. Its flagship product is the pharmaceutical distribution platform serving hospitals, clinics, health operators, and public health agencies with a catalog of 5,000+ medication SKUs (ethical, generic, similar, biological, and imported) sourced from 70+ laboratory partners. The VNova Delivery sub-brand extends the platform to B2C direct-to-patient deliveries, while a suite of add-on modules — Rastreabilidade e Monitoramento (traceability integrated with SNGPC), Armazenagem Inteligente (temperature-controlled storage), Suporte Farmacêutico (pharmaceutical consulting), Gestão Operacional (operational analytics), and Soluções Tecnológicas (system integration) — layers on top of the core distribution engine to provide a comprehensive pharmaceutical supply chain ecosystem.

Differentiator

Problem solved

Functional benefit

Products and services

• Hospinova Distribuidora Farmacêutica (Core B2B Pharmaceutical Distribution) Full-service B2B pharmaceutical distribution platform serving hospitals, clinics, health insurance operators, and public health agencies across all 26 Brazilian states and the Federal District. Offers a catalog of over 5,000 medications (ethical, generic, similar, biological, and imported) from 70+ laboratory partners, with real-time traceability, temperature-controlled logistics, and specialized pharmaceutical support services.
• VNova Delivery (Patient Direct B2C Delivery) Direct-to-consumer delivery arm of Hospinova serving individual patients (pessoa física) across Brazil. Operates via a dedicated logistics network with temperature control and GPS monitoring to ensure product integrity during last-mile delivery, with WhatsApp-based ordering.
• VNova Medicine Catalog (Digital Pharmaceutical Catalog) Digital catalog platform offering access to over 5,000 medication SKUs across ethical, generic, similar, biological, and imported categories. Supports both B2B (legal entities: hospitals, clinics, health operators, and public bodies) and B2C (individual patients via WhatsApp) purchasing channels.

Quantifiable outcome

• 100% traceability of distributed medications
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Venancio (Grupo Venancio)coreStrategic or Co-development PartnerHospinova is an empresa (company) of Grupo Venancio. The parent company relationship provides strategic direction and operational support, with VNova Delivery created as part of this ecosystem to strengthen logistics operations for patient-direct deliveries.
• 70+ Pharmaceutical LaboratoriescoreChannel Partner/ Reseller/ DistributorPartnership with over 70 national and multinational pharmaceutical laboratories forming the supply base for Hospinova's 5,000+ product catalog. Includes ethical, generic, similar, biological, and imported medication suppliers from Brazil and internationally.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Tamoio Distribuidora: Brazilian pharmaceutical distributor focused on institutional clients (hospitals, clinics, public agencies) with national cold-chain coverage. Directly competes with Hospinova on hospital distribution, public-tender participation, and specialty drug handling.
• Profarma Specialty: One of Brazil's largest specialty pharmaceutical distributors, serving hospitals, clinics, and health operators with high-cost and specialty medications. Directly comparable to Hospinova on customer base (institutional healthcare), product mix (specialty/high-cost drugs), and B2B public-tender model.
• Supera Farma: Brazilian pharmaceutical distributor serving hospitals, health operators, and government agencies with specialty and high-cost medications. Comparable to Hospinova in customer segmentation (institutional healthcare), regulatory compliance focus, and specialty drug portfolio.
• Servimed: Large Brazilian pharmaceutical distributor with national reach serving retail pharmacies, hospitals, and public health agencies. Comparable to Hospinova in product breadth, public-tender execution, and multi-segment B2B distribution model.
• DPSP (Distribuidora de Produtos de Saúde): Specialty distributor in Brazil serving hospitals and clinics with medications and hospital supplies, including controlled substances. Direct competitor to Hospinova on hospital distribution and ANVISA-regulated cold-chain logistics.
• CSB Farma: Brazilian pharmaceutical distributor with strong hospital and public-sector presence, distributing medications and hospital supplies. Overlaps with Hospinova on institutional B2B, public-tender (licitações) execution, and ANVISA-compliant cold-chain logistics.

Broad incumbents

• McKesson: Global pharmaceutical distribution and healthcare services incumbent with operations across multiple continents. While not a head-to-head competitor in Brazil's domestic institutional market, McKesson is a broad benchmark for distribution scale, regulated-logistics capability, and value-added services (PBM, analytics) that Hospinova's strategy aspires toward.
• Cencora (formerly AmerisourceBergen): Global pharmaceutical distribution leader offering specialty distribution, physician services, and animal health. A broad incumbent benchmark for the distribution-plus-services model Hospinova is building with its add-on modules (traceability, PBM-like consulting, operational management).
• Raia Drogasil (RD): Brazil's largest retail pharmacy chain with an integrated distribution arm. While primarily retail-focused, RD demonstrates the scale and vertical-integration advantages that mid-tier institutional distributors like Hospinova face when competing for pharmacy and patient-direct volume.

Emerging players

• Panvel: Brazilian retail pharmacy chain expanding into specialty pharmaceutical services and digital health. Comparable to Hospinova's VNova Delivery patient-direct initiative and represents an emerging adjacency that could compete for chronic-disease medication adherence volume.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/hospinova-distribuidora-de-produtos-hospitalares

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hospinova Distribuidora de Produtos Hospitalares